Aminopeptidase N Is an Entry Co-factor Triggering Porcine Deltacoronavirus Entry via an Endocytotic Pathway.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
13 10 2021
Historique:
pubmed: 19 8 2021
medline: 6 11 2021
entrez: 18 8 2021
Statut: ppublish

Résumé

Porcine deltacoronavirus (PDCoV) is a recently discovered coronavirus that poses a potential threat to the global swine industry. Although we know that aminopeptidase N (APN) is important for PDCoV replication, it is unclear whether it is the primary functional receptor, and the mechanism by which it promotes viral replication is not fully understood. Here, we systematically investigated the roles of porcine APN (pAPN) during PDCoV infection of nonsusceptible cells, including in viral attachment and internalization. Using a viral entry assay, we found that PDCoV can enter nonsusceptible cells but then fails to initiate efficient replication. pAPN and PDCoV virions clearly colocalized with the endocytotic markers RAB5, RAB7, and LAMP1, suggesting that pAPN mediates PDCoV entry by an endocytotic pathway. Most importantly, our study shows that regardless of which receptor PDCoV engages, only entry by an endocytotic route ultimately leads to efficient viral replication. This knowledge should contribute to the development of efficient antiviral treatments, which are especially useful in preventing cross-species transmission.

Identifiants

pubmed: 34406863
doi: 10.1128/JVI.00944-21
pmc: PMC8513460
doi:

Substances chimiques

Receptors, Coronavirus 0
Peptide Hydrolases EC 3.4.-
CD13 Antigens EC 3.4.11.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0094421

Subventions

Organisme : MOST | National Key Research and Development Program of China (973 Program)
ID : 2016YFD0500100

Références

J Virol. 2003 Jan;77(2):830-40
pubmed: 12502799
Nature. 1992 Jun 4;357(6377):417-20
pubmed: 1350661
J Biol Chem. 2019 Jun 21;294(25):9830-9843
pubmed: 31068417
Trends Mol Med. 2008 Aug;14(8):361-71
pubmed: 18603472
J Clin Microbiol. 2014 Jan;52(1):234-43
pubmed: 24197882
J Virol. 2018 May 29;92(12):
pubmed: 29618640
Adv Virus Res. 2016;96:29-57
pubmed: 27712627
Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5135-E5143
pubmed: 29760102
Emerg Microbes Infect. 2018 Apr 11;7(1):65
pubmed: 29636467
J Virol. 2006 Jul;80(14):7270-4
pubmed: 16809333
Virology. 2020 Feb;541:136-140
pubmed: 32056711
J Med Chem. 2018 Aug 09;61(15):6468-6490
pubmed: 29630364
Elife. 2020 Sep 02;9:
pubmed: 32876563
J Virol. 2006 May;80(9):4211-9
pubmed: 16611880
J Virol. 2012 May;86(10):5481-96
pubmed: 22398294
J Virol. 2014 Jun;88(12):7070-82
pubmed: 24719429
J Virol. 2010 Apr;84(7):3134-46
pubmed: 19906932
Curr Opin Virol. 2019 Feb;34:39-49
pubmed: 30654269
Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9864-9
pubmed: 27528677
J Virol. 2012 Apr;86(7):3995-4008
pubmed: 22278237
J Virol. 1996 Dec;70(12):8669-74
pubmed: 8970993
J Virol. 2007 Oct;81(19):10758-68
pubmed: 17626088
PLoS Pathog. 2014 Nov 06;10(11):e1004502
pubmed: 25375324
J Virol. 2017 Feb 14;91(5):
pubmed: 28077633
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81
pubmed: 16081529
J Virol. 2018 Nov 27;92(24):
pubmed: 30258004
Virus Res. 2016 Dec 2;226:50-59
pubmed: 27086031
mBio. 2014 Feb 25;5(2):e00884-14
pubmed: 24570370
J Virol. 2015 Dec;89(23):11858-70
pubmed: 26378164
Viruses. 2019 Jun 21;11(6):
pubmed: 31234434
Transbound Emerg Dis. 2018 Jun;65(3):660-675
pubmed: 29392870
Arch Virol. 2017 Aug;162(8):2357-2362
pubmed: 28374120
Emerg Microbes Infect. 2020 Dec;9(1):457-468
pubmed: 32090689
mBio. 2015 Mar 10;6(2):e00064
pubmed: 25759498
J Virol. 1985 Dec;56(3):912-20
pubmed: 2999444
J Virol. 2009 Nov;83(21):11133-41
pubmed: 19706706
J Virol. 2015 Mar;89(6):3076-92
pubmed: 25552712
Nature. 1992 Jun 4;357(6377):420-2
pubmed: 1350662

Auteurs

Yue-Lin Yang (YL)

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institutegrid.38587.31 of the Chinese Academy of Agricultural Sciences, Harbin, China.
State Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing, China.

Jianbo Liu (J)

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institutegrid.38587.31 of the Chinese Academy of Agricultural Sciences, Harbin, China.

Tong-Yun Wang (TY)

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institutegrid.38587.31 of the Chinese Academy of Agricultural Sciences, Harbin, China.

Meng Chen (M)

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institutegrid.38587.31 of the Chinese Academy of Agricultural Sciences, Harbin, China.

Gang Wang (G)

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institutegrid.38587.31 of the Chinese Academy of Agricultural Sciences, Harbin, China.

Yong-Bo Yang (YB)

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institutegrid.38587.31 of the Chinese Academy of Agricultural Sciences, Harbin, China.

Xin Geng (X)

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institutegrid.38587.31 of the Chinese Academy of Agricultural Sciences, Harbin, China.

Ming-Xia Sun (MX)

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institutegrid.38587.31 of the Chinese Academy of Agricultural Sciences, Harbin, China.

Fandan Meng (F)

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institutegrid.38587.31 of the Chinese Academy of Agricultural Sciences, Harbin, China.

Yan-Dong Tang (YD)

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institutegrid.38587.31 of the Chinese Academy of Agricultural Sciences, Harbin, China.

Li Feng (L)

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institutegrid.38587.31 of the Chinese Academy of Agricultural Sciences, Harbin, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH